Centralising ECG trial data can cut costs 40%, says ERT

By Gareth Macdonald

- Last updated on GMT

Related tags: Contract research organization

Centralising ECG trial data can cut costs 40%, says ERT
E Research Technology (ERT) launches Centralised Cardiac Safety 2.0 (CCS 2.0) service for ECG data and says approach improves efficiency, cuts costs and helps sponsors reach database lock quicker than distributed model.

Outsourcing-pharma spoke with ERT executive VP of sales and marketing John Blakeley who said allowing investigators to focus on medicine rather than on the tech used to drive trials was a key motivation for developing the new service and software.

Blakeley explained that, unlike current approaches in which ECGs are collated manually at trial sites, the CCS 2.0 model is to feed information to a centralised repository enabling real time analysis, improving data quality and reducing investigator workload.

He also suggested that centralising ECG data is 35 to 40 per cent cheaper than the decentralised approach which, given the cost pressures facing pharma firms and contract research organisations (CRO), is sure to attract industry attention.

Related news

Show more

Related products

show more

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars